Clinical Trial Update: Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

View source ↗

Summary

The expanded access program for TAK-113 in adults with metastatic colorectal cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TAK-113

Snippet

Sponsor: Takeda | Conditions: Colorectal Cancer | Status: NO_LONGER_AVAILABLE